How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Percutaneous Endoscopic Gastrostomy (PEG) Tube Market
- By Product Type: Low Profile PEG Tubes, Standard PEG Tubes, Balloon Retention PEG Tubes, Pull-Type PEG Tubes, Push-Type PEG Tubes
- By Material: Silicone PEG Tubes, Polyurethane PEG Tubes, Latex PEG Tubes
- By Application: Enteral Feeding, Medication Administration, Gastrointestinal Decompression
- By End User: Hospitals, Home Care Settings, Long-term Care Facilities, Ambulatory Surgical Centers
- By Insertion Technique: Pull Technique, Push Technique, Introducer Technique
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Low Profile PEG Tubes leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 294 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Percutaneous Endoscopic Gastrostomy (PEG) Tube Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material 3
Application 3
End User 4
Insertion Technique 3
Companies profiled
Medtronic plc
Boston Scientific Corporation
Cook Medical (a subsidiary of Medtronic)
ConvaTec Group PLC
Becton
Dickinson and Company (BD)
Teleflex Incorporated
Smiths Medical (a division of Smiths Group plc)
C.R. Bard
Inc. (a subsidiary of BD)
Fresenius Kabi AG
Halyard Health
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Cook Medical (a subsidiary of Medtronic)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →ConvaTec Group PLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Teleflex Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Smiths Medical (a division of Smiths Group plc)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →C.R. Bard
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Inc. (a subsidiary of BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Fresenius Kabi AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Halyard Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Inc. (now part of Owens & Minor
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Inc.)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Nipro Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Sewoon Medical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Olympus Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,304M by 2033 · 8.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Low Profile PEG Tubes28.6
- Standard PEG Tubes19.1
- Balloon Retention PEG Tubes9.7
- Pull-Type PEG Tubes21.8
- Push-Type PEG Tubes20.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,389M → $2,836M · 9.3%
Europe$968.0M → $1,888M · 8.7%
Asia Pacific$883.8M → $1,577M · 7.5%
Latin America$547.1M → $1,152M · 9.8%
Middle East and Africa$420.9M → $898.0M · 9.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.832026
8.832027
8.842028
8.862029
8.862030
8.892031
8.892032
8.902033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic plc25.3
- Boston Scientific Corporation12.1
- Cook Medical (a subsidiary of Medtronic)6.2
- ConvaTec Group PLC5.9
- Becton12.7
- Dickinson and Company (BD)9.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type21.2%
Material11.7%
Application14.8%
End User26.6%
Insertion Technique25.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.0
- Europe22.6
- Asia Pacific18.9
- Latin America13.8
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 89 | 80 | 75 | 90 | 81 | 74 | 82 |
| Boston Scientific Corporation | 91 | 88 | 91 | 68 | 79 | 75 | 82 |
| Cook Medical (a subsidiary of Medtronic) | 80 | 75 | 64 | 66 | 87 | 76 | 75 |
| ConvaTec Group PLC | 73 | 64 | 79 | 79 | 68 | 74 | 73 |
| Becton | 72 | 57 | 56 | 51 | 73 | 63 | 62 |
| Dickinson and Company (BD) | 61 | 49 | 67 | 54 | 52 | 67 | 58 |
| Teleflex Incorporated | 61 | 59 | 62 | 62 | 58 | 46 | 58 |
| Smiths Medical (a division of Smiths Group plc) | 43 | 40 | 57 | 45 | 35 | 60 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic plc
- Boston Scientific Corporation
- Cook Medical (a subsidiary of Medtronic)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic plc | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Boston Scientific Corporation | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cook Medical (a subsidiary of Medtronic) | ◐ | ✓ | ◐ | − | ◐ | ✓ |
| ConvaTec Group PLC | ◐ | ✓ | ✓ | ◐ | − | − |
| Becton | ✓ | − | − | ◐ | ◐ | − |
| Dickinson and Company (BD) | − | − | ◐ | − | − | ◐ |
| Teleflex Incorporated | ◐ | − | ◐ | − | − | − |
| Smiths Medical (a division of Smiths Group plc) | − | − | ◐ | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic plc82
2Boston Scientific Corporation82
3Cook Medical (a subsidiary of Medtronic)75
4ConvaTec Group PLC73
5Becton62
6Dickinson and Company (BD)58
7Teleflex Incorporated58
8Smiths Medical (a division of Smiths Group plc)47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Medtronic plcBoston Scientific Corporation
Challenger2
Strong scale, closing on the leaders.
Cook Medical (a subsidiary of Medtronic)ConvaTec Group PLC
Contender3
Focused players with pockets of strength.
BectonDickinson and Company (BD)Teleflex Incorporated
Niche1
Specialists in a single segment or region.
Smiths Medical (a division of Smiths Group plc)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Percutaneous Endoscopic Gastrostomy (PEG) Tube Market — a $663M beachhead inside a $10.1B market.
Beachhead (SOM)$663Mobtainable near-term
Serviceable (SAM)$3.75Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Low Profile PEG Tubes
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Standard PEG Tubes
Strong fit — clear ROI and a fast path to value.
End user69 fit
Balloon Retention PEG Tubes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel30%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Percutaneous Endoscopic Gastrostomy (PEG) Tube Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified24%
Evaluation13%
Closed-won6%
$11.4KCAC
$63KLTV
5.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Percutaneous Endoscopic Gastrostomy (PEG) Tube Market is a high-growth opportunity — $11.7B by 2033, compounding at 10.8%.
TAM · 2025$5.15Btoday
TAM · 2033$11.7Bforecast
CAGR10.8%2027–2033
Cumulative$72.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$11.7BTotal addressable market
SAM$4.58BServiceable available market
SOM$734MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.8% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$11.7BLarge & growingTAM by 2033 at 10.8% CAGR
$4.58BServiceable nowreachable with today’s model
$734MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$9.14BBear7.0% CAGR
$11.7BBase10.8% CAGR
$15.0BBull14.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Percutaneous Endoscopic Gastrostomy (PEG) Tube Market — a $11.4B market by 2033. Plan: grow share from 6.7% to 12.6%.
Market size · 2033$11.4Btotal addressable
Market CAGR10.9%2027–2033
Target share12.6%from 6.7% today
Revenue ambition$1.43Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.7% | 12.6% | Behind |
| Revenue | $777M | $1.43B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 37.5% | 40.5% | At risk |
| Customer retention | 87.0% | 96.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $175M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Percutaneous Endoscopic Gastrostomy (PEG) Tube Market conversation — a $2.16B market you can size, segment and defend in minutes.
Market size · 2033$2.16Btotal opportunity
Growth4.9%CAGR to 2033
Addressable buyers1,255+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 2 mopayback period
$68K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Medtronic plcBoston Scientific CorporationCook Medical (a subsidiary of Medtronic)ConvaTec Group PLCBectonDickinson and Company (BD)Teleflex IncorporatedSmiths Medical (a division of Smiths Group plc)+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Percutaneous Endoscopic Gastrostomy (PEG) Tube Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Percutaneous Endoscopic Gastrostomy (PEG) Tube Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Percutaneous Endoscopic Gastrostomy Kit Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportPercutaneous Decompression System Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportPercutaneous Coronary Intervention Guidance Devices Market
Market size, share, segmentation and regional forecast.
$987M market · 2025 base year
View reportPercutaneous Coronary Intervention Balloon Catheter Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPercutaneous Atherectomy Catheter Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportPercussion Massage Gun Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportPercussion Expectoration Machine Market
Market size, share, segmentation and regional forecast.
$358M market · 2025 base year
View reportPerampanel Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportPeramivir Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportPeramivir API Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportPeptide Vaccine Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportPeptide Therapy Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.